HOME >> BIOLOGY >> NEWS
Giant plant-eating dinosaur found; two cast skeletons to be unveiled

WASHINGTON -- A primitive, long-necked dinosaur that weighed an estimated 20 tons and grew to a length of 70 feet is the newest species to be plucked from the African Sahara by a team led by paleontologist Paul Sereno of the University of Chicago.

To be unveiled at a news conference at the National Geographic Society, a sponsor of the project, the species was discovered in the Republic of Niger and is described in the Nov. 12 issue of the journal Science. Full-size cast skeletons of a 60-foot-long adult, rearing to a height of more than 30 feet, and a juvenile posed in mid stride have been constructed.

Toiling in temperatures exceeding 120, Sereno's team excavated tons of bone and rock on a 1997 expedition and then spent two years cleaning and studying the bones. "With 95 percent of its skeleton preserved, the new species stands as the most complete long-necked dinosaur ever discovered from the Cretaceous period," said Sereno.

The new dinosaur, named Jobaria tiguidensis, lived about 135 million years ago in the Cretaceous, when open forests and broad rivers characterized the region that is desert today. Jobaria refers to "Jobar," a creature in the legends of the local Tuareg nomads that is linked to the exposed bones; tiguidensis refers to a cliff near the excavation sites.

The main graveyard contained bones of several adults and juveniles, suggesting that Jobaria once roamed in herds of mixed age, Sereno said. Although an ancient flash flood quickly buried the animals, some may have died at the hands of the chief meat-eating dinosaur of the time, Afrovenator, a 27-foot-long predator previously discovered in the same area by Sereno's team. Tooth marks are present on the ribs of one of the juvenile skeletons.

Jobaria doesn't fit into any recognized family of long-necked dinosaurs, or sauropods. Rather Jobaria represents an ancient sauropod lineage that survived and flourished only in Africa during the Cretaceous. Unlike other Creta
'"/>

Contact: Barbara Moffet
bmoffet@ngs.org
202-857-7756
National Geographic Society
11-Nov-1999


Page: 1 2

Related biology news :

1. Giant bloom fades, science continues
2. Scientist probes fossil oddity: Giant redwoods near North Pole
3. Giant icebergs, unprecedented ice conditions threaten Antarctic penguin colonies
4. Giant pandas have plenty of genetic diversity
5. From dolphins to the Giant Panda - chemistry at SeaWorld and the San Diego Zoo
6. Giant jellies invade Gulf of Mexico threatening shrimp fishery
7. First Dinosaur Embryo Skin Discovered -- Unhatched Embryos Are First Ever Found Of Giant-Plant Eating Dinosaurs
8. Computer imaging of Archeopteryx skull suggests this dinosaur-bird link could fly
9. Two dinosaurs from Africa give clues to continents split
10. A lost world: Two previously unknown dinosaurs discovered in Antarctica
11. Princeton paleontologist produces evidence for new theory on dinosaur extinction

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Giant plant eating dinosaur found two cast skeletons unveiled

(Date:3/11/2015)... , March 11, 2015   The ... its platform to scientifically measure and harness music ... to real-time biometrics and objective measurements of physiology, ... music at scale in large populations. It is ... technologists and clinicians perform rigorous studies and accelerate ...
(Date:3/10/2015)... 2015  NXT-ID, Inc. (NASDAQ: NXTD ... biometric authentication company focused on the growing mobile ... has been named the "Number One Best Tech ... Rethink Modern ( http://www.rethinkmodern.com/ ) is a web ... and lifestyle that have a unique function or design.  ...
(Date:3/2/2015)... SAN JOSE, Calif. , March 2, 2015 ... ), the leading developer of human interface solutions, ... ID technology that is designed to enable rapid ... Synaptics Natural ID™ module for gaming is a ... and ODMs the ability to quickly integrate fingerprint ...
Breaking Biology News(10 mins):Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 2Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 3NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 2NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 3NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 4Synaptics Unveils New Fingerprint ID Solution for Gamers 2Synaptics Unveils New Fingerprint ID Solution for Gamers 3
(Date:3/30/2015)... , March 30, 2015 CASI Pharmaceuticals, Inc. ... the acquisition, development and commercialization of innovative therapeutics addressing ... market with a commercial focus on China ... Drug Administration (CFDA) has approved the Company,s application to ... clear cell carcinoma (OCCC) patients for its proprietary drug ...
(Date:3/30/2015)... GERMANTOWN, Md. , March 30, 2015  /PRNewswire/ ... a leader in synthetic biology, and Merck Serono, ... Germany , today announced an exclusive ... commercialize Chimeric Antigen Receptor T-cell (CAR-T) cancer therapies. ... to develop innovative therapies that modulate the immune ...
(Date:3/30/2015)... Washington, USA (PRWEB) March 29, 2015 ... and the United States and plenary talks by four ... SPIE Optics + Optoelectronics next month in ... technical presentations in 17 conferences alongside a two-day exhibition. ... and photonics , the event will run 13-16 April ...
(Date:3/30/2015)... 2015  Naldemedine, an investigational peripherally acting mu-opioid ... Co., Ltd., met its primary and secondary endpoints ... the treatment of opioid-induced constipation (OIC) in adult ... Study results showed that naldemedine (0.2 mg tablet ... of spontaneous bowel movement (SBM) compared with placebo ...
Breaking Biology Technology:CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 4CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 5Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 2Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 3Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 4Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 2Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 3Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3
Cached News: